Recombinant fragment Predicted to work with:
Highly pure recombinant Human IL17D.
Lyophilised:Centrifuge vial prior to opening. Reconstitute in sterile PBS containing 0.1% BSA to a concentration of 1.0 mg/ml. Please note that if you receive this product in liquid form it has already been reconstituted as described and no further reconstitution is necessary.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C or -80°C. Avoid freeze / thaw cycle.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 0.1 - 0.2 µg/ml. Predicted molecular weight: 22 kDa. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human IL17D is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
Use a concentration of 0.25 - 1 µg/ml. (using 100 µl/well antibody solution).
ab115034, in conjunction with a Polyclonal Anti-Human IL17D as a capture antibody, allows the detection of at least 0.2-0.4 ng/well of recombinant Human IL17D.
Induces expression of IL-6, IL-8, and GM-CSF from endothelial cells.
Expressed preferentially in adipose, skeletal muscle and CNS.